Related content

Changes of urinary phospholipids in the chronic kidney disease patients

By Yang Wen-Ling   Bai Qiong   Li Dan-Dan   A Ta-La   Wang Song   Zhao Rong-Sheng   Nie Hong-Gang   Zhang Ai-Hua   Wang Tao   Fan Min-Hua  

Biomarkers, Vol. 18, Iss. 7, 2013-11 ,pp. : 601-606

Informa Healthcare

Access to resources Recommend Favorite

Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease

By Bao Yu-Shi   Ji Ying   Zhao Shi-Lei   Ma Lin-Lin   Xie Ru-Juan   Na Shi-Ping  

Biomarkers, Vol. 18, Iss. 5, 2013-08 ,pp. : 379-385

Informa Healthcare

Access to resources Recommend Favorite

Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease

By Calderón-Salinas J.   Muñoz-Reyes E.   Guerrero-Romero J.   Rodríguez-Morán M.   Bracho-Riquelme R.   Carrera-Gracia M.   Quintanar-Escorza M.  

Molecular and Cellular Biochemistry, Vol. 357, Iss. 1-2, 2011-11 ,pp. : 171-179

Springer Publishing Company

Access to resources Recommend Favorite

Detection of advanced oxidation protein products in patients with chronic kidney disease by a novel monoclonal antibody

By Liu Beiyi   Hou Xiaorui   Zhou Qiugen   Tian Jianwei   Zhu Ping   Xu Jie   Hou Fanfan   Fu Ning  

Free Radical Research, Vol. 45, Iss. 6, 2011-06 ,pp. : 662-671

Informa Healthcare

Access to resources Recommend Favorite

Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study

By Rangel-López Angélica  

Mutagenesis, Vol. 28, Iss. 2, 2013-03 ,pp. : 219-225

Oxford University Press

Access to resources Recommend Favorite